- Home
- NRG vs PODD Comparison
NRG vs PODD Comparison
Compare NRG & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRG
- PODD
- Stock Information
- Founded
- NRG 1989
- PODD 2000
- Country
- NRG United States
- PODD United States
- Employees
- NRG N/A
- PODD N/A
- Industry
- NRG Electric Utilities: Central
- PODD Medical/Dental Instruments
- Sector
- NRG Utilities
- PODD Health Care
- Exchange
- NRG Nasdaq
- PODD Nasdaq
- Market Cap
- NRG 17.6B
- PODD 17.2B
- IPO Year
- NRG 2000
- PODD 2007
- Fundamental
- Price
- NRG $97.86
- PODD $246.80
- Analyst Decision
- NRG Strong Buy
- PODD Buy
- Analyst Count
- NRG 8
- PODD 17
- Target Price
- NRG $124.00
- PODD $294.65
- AVG Volume (30 Days)
- NRG 3.2M
- PODD 878.5K
- Earning Date
- NRG 05-06-2025
- PODD 05-08-2025
- Dividend Yield
- NRG 1.79%
- PODD N/A
- EPS Growth
- NRG N/A
- PODD 96.55
- EPS
- NRG 4.99
- PODD 5.78
- Revenue
- NRG $28,130,000,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- NRG $12.98
- PODD $20.53
- Revenue Next Year
- NRG $2.22
- PODD $17.42
- P/E Ratio
- NRG $19.61
- PODD $42.67
- Revenue Growth
- NRG N/A
- PODD 22.07
- 52 Week Low
- NRG $65.11
- PODD $160.19
- 52 Week High
- NRG $117.26
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- NRG 52.39
- PODD 42.59
- Support Level
- NRG $95.38
- PODD $241.54
- Resistance Level
- NRG $98.60
- PODD $258.00
- Average True Range (ATR)
- NRG 6.14
- PODD 13.13
- MACD
- NRG 0.77
- PODD -0.61
- Stochastic Oscillator
- NRG 76.46
- PODD 34.84
About NRG NRG Energy Inc.
NRG Energy is one of the largest retail energy providers in the us, with 6 million customers. Vivint Smart Home, which NRG acquired in 2023, has 2 million home services customers. NRG also is one of the largest us independent power producers, with 13 gigawatts of coal, gas, and oil power generation capacity primarily in Texas. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.